Cargando…
Inhibition of ITGB1 enhance the anti-tumor effect of cetuximab in colorectal cancer cell
BACKGROUND: Colorectal cancer is the second commonly seen cancer around the world and accounts for 13% of all human cancers. Among them, 25% of all case were diagnosed with metastasis and 50% occurs metastasis during the development of disease. Cetuximab is a chimeric monoclonal antibody against epi...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337548/ https://www.ncbi.nlm.nih.gov/pubmed/32629699 http://dx.doi.org/10.1097/MD.0000000000020944 |